CAP-1160

N/A

Report date: 2024/10/17 17:05:46
NME

Base Information

Drug NameCAP-1160
Drug Alias NameCAP-1160CAP1160
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCrystallin Alpha A modulators
TargetsAlpha-Crystallin A Chain
Therapy Area/IndicationsCataract
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPlex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPlex Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCataract
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A